6-[2-(adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2004-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JSBMB.2004.06.004PMID 15544928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basis for abnormal desquamation and permeability barrier dysfunction in RXLI.

  2004cited by this paper
• Steroidal oxathiazine inhibitors of estrone sulfatase.

  2003cited by this paper
• High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer.

  2003cited by this paper
• Steroid sulphatase inhibitors for breast cancer therapy.

  2003cited by this paper
• 6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.

  2003cited by this paper
• Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.

  2003cited by this paper
• Steroid sulfatase inhibitors

  2003cited by this paper
• Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.

  2003cited by this paper
• Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.

  2003cited by this paper
• Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.

  2002cited by this paper
• Cutaneous androgen metabolism: basic research and clinical perspectives.

  2002cited by this paper
• Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.

  2002cited by this paper
• 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.

  2002cited by this paper
• In situ production of estrogens in human breast carcinoma

  2002cited by this paper
• Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption.

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• The effect of 2‐methoxyoestrone‐3‐O‐sulphamate on the growth of breast cancer cells and induced mammary tumours

  2000cited by this paper
• Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors.

  2000cited by this paper
• In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE.

  2000cited by this paper
• Elevated steroid sulfatase expression in breast cancers.

  2000cited by this paper
• Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.

  1999cited by this paper
• Estrone sulfatase versus estrone sulfotransferase in human breast cancer: potential clinical applications.

  1999cited by this paper
• Dehydroepiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines.

  1998cited by this paper
• Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study.

  1997cited by this paper
• Development of an Oral Formulation for Oestrone 3-O-Sulphamate, a Potent Sulphatase Inhibitor

  1996cited by this paper
• Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris

  1995cited by this paper
• In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone‐3‐O‐sulphamate

  1995cited by this paper
• Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehydroepiandrosterone.

  1994cited by this paper
• The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.

  1993cited by this paper
• Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls.

  1992cited by this paper
• Intracrinology.

  1991cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper
• Importance of estrogen sulfates in breast cancer.

  1989cited by this paper
• Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

  1988cited by this paper
• The anionic sulphonylamine mechanism in the hydrolysis of aryl sulphamates

  1986cited by this paper
• New assay for steroid sulfatase (EC 3.1.6.2) and its application for studies of human placental and skin sulfatase.

  1984cited by this paper
• Steroid sulphatase inhibitors: A new endocrine therapy

  1984cited by this paper
• Androgen excess in cystic acne.

  1983cited by this paper
• Steroid sulfatase of human leukocytes and epidermis and the diagnosis of recessive X-linked ichthyosis.

  1981cited by this paper
• Steroid sulfatase deficiency and X-linked ichthyosis.

  1979cited by this paper
• Solubilization and partial purification of steroid sulfatase from rat liver: characterization of estrone sulfatase.

  1976cited by this paper
• The metabolism of [4-14C] dehydroepiandrosterone by human skin in vitro. I. Transformation in vitro of [4-14C] dehydroepiandrosterone into Androst-4-ene-3,17-dione, testosterone and androsterone by normal human male and female skin slices.

  1970cited by this paper
• MALE HORMONE SUBSTANCE: A PRIME FACTOR IN ACNE1

  1941cited by this paper

• Challenging medicinal chemistry: ups and downs in a drug discovery project

  2018cites this paper
• Targets to treat androgen excess in polycystic ovary syndrome

  2015cites this paper
• Sulfamic acid and its N- and O-substituted derivatives.

  2014cites this paper
• Sulfatase inhibitors: a patent review

  2013cites this paper
• Hormonal enzymatic systems in normal and cancerous human breast: control, prognostic factors, and clinical applications

  2012cites this paper
• Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?

  2011cites this paper
• Steroid sulfatase inhibitors: a review covering the promising 2000-2010 decade.

  2011cites this paper
• Shu-Gan-Liang-Xue decoction simultaneously down-regulates expressions of aromatase and steroid sulfatase in estrogen receptor positive breast cancer cells

  2011cites this paper
• Bicyclic Derivatives of the Potent Dual Aromatase–Steroid Sulfatase Inhibitor 2‐Bromo‐4‐{[(4‐cyanophenyl)(4H‐1,2,4‐triazol‐4‐yl)amino]methyl}phenylsulfamate: Synthesis, SAR, Crystal Structure, and in vitro and in vivo Activities

  2010cites this paper
• Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy.

  2008cites this paper
• Sexual Hormones in Human Skin

  2007cites this paper
• Sexual hormones in human skin.

  2007cites this paper
• Thiosemicarbazones of formyl benzoic acids as novel potent inhibitors of estrone sulfatase.

  2007cites this paper
• Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.

  2005cites this paper